Drug Type Antibody drug conjugate (ADC) |
Synonyms IKS 01, IKS-01 |
Target |
Mechanism DNA inhibitors(DNA inhibitors), DNA alkylating agents, DNA damage modulators |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Lung Cancer | Preclinical | GB | Femtogenix LtdStartup | 06 Jun 2019 |
Ovarian Cancer | Preclinical | GB | Femtogenix LtdStartup | 06 Jun 2019 |
Solid tumor | Preclinical | GB | 22 Jan 2019 |